EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis

Jumpei Temmoku, Tomoyuki Asano, Kenji Saito, Haruki Matsumoto, Yuya Fujita, Makiko Furuya-Yashiro, Naoki Matsuoka, Akira Oda, Hayato Tanabe, Shuzo Sato, Kiori Shio-Yano, Tomomi Sasajima, Yuichiro Kiko, Hiroko Kobayashi, Hiroshi Watanabe, Michio Shimabukuro, Kiyoshi Migita

Modern Rheumatology Case Reports · 2022-01-07 · 6 (1) · 41-46

DOI: 10.1093/mrcr/rxab020 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Type B insulin resistance syndrome (TBIR) is a rare autoimmune disease characterised by autoantibodies targeting insulin receptors. TBIR is often complicated by systemic lupus erythematosus (SLE). We describe the case of a 59-year-old Japanese man with TBIR complicated with lupus nephritis (LN), who presented with nephrotic syndrome and severe hypoglycaemia. Treatment with prednisolone (PSL), mycophenolate mofetil (MMF), and tacrolimus (TAC) resulted in improved SLE activity and glucose intolerance with the reduction of anti-insulin receptor autoantibodies. To the best of our knowledge, this is the first reported case of TBIR complicated with LN that was successfully treated using multitarget therapy with PSL, MMF, and TAC.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →